Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) (2010 - 2026)

Neurocrine Biosciences (NBIX) Property, Plant & Equipment (Net) (2010 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Teva Pharmaceutical Industries 38.77 Bn 35.04 Bn 1.97 Bn 4.00 Bn
2 Zoetis 34.11 Bn 32.16 Bn 1.62 Bn 3.72 Bn
3 United Therapeutics 23.68 Bn 21.53 Bn 648.10 Mn 1.84 Bn
4 Aurora Cannabis 16.48 Bn 16.40 Bn 33.43 Mn 185.80 Mn
5 Neurocrine Biosciences 16.19 Bn 14.88 Bn 800.70 Mn 90.90 Mn
6 Elanco Animal Health 11.44 Bn 11.01 Bn 785.00 Mn 1.40 Bn
7 Alkermes 7.28 Bn 6.77 Bn -116.06 Mn 220.59 Mn
8 Lantheus Holdings 6.48 Bn 5.98 Bn 230.92 Mn 157.56 Mn
9 Hims & Hers Health 6.35 Bn 5.60 Bn 396.79 Mn 333.85 Mn
10 Liquidia 5.74 Bn 5.52 Bn 121.79 Mn 20.84 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 90.90 Mn
Mar 31, 2026 90.90 Mn
Dec 31, 2025 89.80 Mn
Dec 31, 2025 89.80 Mn
Sep 30, 2025 97.30 Mn
Sep 30, 2025 97.30 Mn
Jun 30, 2025 91.70 Mn
Jun 30, 2025 91.70 Mn
Mar 31, 2025 87.00 Mn
Mar 31, 2025 87.00 Mn
Dec 31, 2024 82.60 Mn
Dec 31, 2024 82.60 Mn
Sep 30, 2024 80.00 Mn
Sep 30, 2024 80.00 Mn
Jun 30, 2024 80.10 Mn
Jun 30, 2024 80.10 Mn
Mar 31, 2024 75.30 Mn
Mar 31, 2024 75.30 Mn
Dec 31, 2023 70.80 Mn
Dec 31, 2023 70.80 Mn